Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (177) 177
life sciences & biomedicine (176) 176
humans (157) 157
male (136) 136
female (128) 128
middle aged (119) 119
cardiovascular system & cardiology (117) 117
aged (113) 113
cardiac & cardiovascular systems (113) 113
biological and medical sciences (89) 89
medical sciences (89) 89
coronary heart disease (75) 75
abridged index medicus (74) 74
treatment outcome (58) 58
cardiology. vascular system (56) 56
heart attacks (50) 50
heart (47) 47
mortality (46) 46
myocardial infarction (46) 46
acute coronary syndromes (43) 43
risk factors (43) 43
care and treatment (40) 40
acute coronary syndrome - drug therapy (35) 35
drug therapy (35) 35
cardiovascular (34) 34
double-blind method (34) 34
medicin och hälsovetenskap (33) 33
general & internal medicine (32) 32
medicine, general & internal (32) 32
cardiac patients (31) 31
follow-up studies (30) 30
cardiovascular disease (29) 29
medical and health sciences (29) 29
pharmacology. drug treatments (29) 29
kardiologi (28) 28
platelet aggregation inhibitors - therapeutic use (28) 28
adult (27) 27
cardiac and cardiovascular systems (27) 27
cardiology (27) 27
peripheral vascular disease (27) 27
stroke (27) 27
electrocardiography (26) 26
myocardial infarction - mortality (26) 26
heart attack (25) 25
clinical medicine (24) 24
clinical trials (24) 24
hemorrhage - chemically induced (24) 24
klinisk medicin (24) 24
patient outcomes (24) 24
myocarditis. cardiomyopathies (23) 23
acute coronary syndrome (21) 21
cardiovascular diseases (21) 21
coronary artery bypass (21) 21
cardiology and cardiovascular medicine (20) 20
coronary vessels (20) 20
drug therapy, combination (19) 19
myocardial infarction - drug therapy (19) 19
patients (19) 19
time factors (19) 19
analysis (17) 17
coronary artery disease (17) 17
kaplan-meier estimate (17) 17
prospective studies (17) 17
blood. blood coagulation. reticuloendothelial system (16) 16
confidence intervals (16) 16
ischemia (16) 16
survival analysis (16) 16
blood and lymphatic vessels (15) 15
platelet aggregation inhibitors - adverse effects (15) 15
pyridines - administration & dosage (15) 15
risk assessment (15) 15
thrombin (15) 15
bleeding (14) 14
dosage and administration (14) 14
pyridines - therapeutic use (14) 14
aged, 80 and over (13) 13
anticoagulants - therapeutic use (13) 13
aspirin (13) 13
cerebral infarction (13) 13
fibrinolytic agents - therapeutic use (13) 13
health aspects (13) 13
myocardial infarction - etiology (13) 13
myocardial infarction - therapy (13) 13
proportional hazards models (13) 13
secondary prevention (13) 13
acute coronary syndrome - mortality (12) 12
diabetes (12) 12
dose-response relationship, drug (12) 12
enoxaparin - administration & dosage (12) 12
heart diseases (12) 12
heart failure (12) 12
heparin - therapeutic use (12) 12
myocardial infarction - epidemiology (12) 12
percutaneous coronary intervention (12) 12
platelet aggregation inhibitors - administration & dosage (12) 12
prognosis (12) 12
stroke - prevention & control (12) 12
usage (12) 12
acute coronary syndrome - diagnosis (11) 11
acute coronary syndrome - therapy (11) 11
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016
by Chew, Derek P., MBBS MPH FRACP and Scott, Ian A., MBBS FRACP MHA and Cullen, Louise, MBBS FACEM PhD and French, John K., BMedSC MBChb PhD and Briffa, Tom G., PhD and Tideman, Philip A., MBBS FRACP FCSANZ and Woodruffe, Stephen, BAppSci (HMS) and Kerr, Alistair and Branagan, Maree, MPH and Aylward, Philip E.G., BM BCh PhD FRACP and NHFA/CSANZ ACS Guideline 2016 Executive Working Group and NHFA CSANZ ACS Guideline Executive
Heart, lung & circulation, ISSN 1443-9506, 2016, Volume 25, Issue 9, pp. 895 - 951
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | New Zealand | Societies, Medical | Humans | Acute Coronary Syndrome - diagnosis | Acute Coronary Syndrome - physiopathology | Acute Coronary Syndrome - therapy | Female | Male | Thoracic Surgery | Australia | Practice Guidelines as Topic | Heart failure | Medical colleges | Care and treatment | Emergency medicine | Practice guidelines (Medicine) | Cardiology | Coronary heart disease | Epidemiology | Trade and professional associations | Cardiovascular agents | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Bivalirudin for Patients with Acute Coronary Syndromes
by Stone, Gregg W and McLaurin, Brent T and Cox, David A and Bertrand, Michel E and Lincoff, A. Michael and Moses, Jeffrey W and White, Harvey D and Pocock, Stuart J and Ware, James H and Feit, Frederick and Colombo, Antonio and Aylward, Philip E and Cequier, Angel R and Darius, Harald and Desmet, Walter and Ebrahimi, Ramin and Hamon, Martial and Rasmussen, Lars H and Rupprecht, Hans-Jürgen and Hoekstra, James and Mehran, Roxana and Ohman, E. Magnus and ACUITY Investigators
The New England journal of medicine, ISSN 0028-4793, 11/2006, Volume 355, Issue 21, pp. 2203 - 2216
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | General aspects | Medical sciences | Coronary heart disease | Recombinant Proteins - therapeutic use | Humans | Middle Aged | Heparin - therapeutic use | Male | Enoxaparin - therapeutic use | Recombinant Proteins - adverse effects | Angioplasty, Balloon, Coronary | Angina, Unstable - drug therapy | Aged, 80 and over | Adult | Female | Drug Therapy, Combination | Myocardial Ischemia - epidemiology | Kaplan-Meier Estimate | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Hirudins - adverse effects | Angina, Unstable - therapy | Coronary Artery Bypass | Aged | Peptide Fragments - adverse effects | Peptide Fragments - therapeutic use | Hemorrhage - chemically induced | Aggregation | Evaluation | Blood platelets | Drug therapy | Heart attacks | Medical imaging | Mortality | Informed consent | Clinical medicine | Angina pectoris | Acute coronary syndromes | Health education | Patients | Index Medicus | Abridged Index Medicus | Bypass cardiopulmonar | Bypass cardiopulmonary | Malalties coronàries | Anticoagulants (Medicine) | Heparin | Heparina | Anticoagulants (Medicina) | Coronary diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Enoxaparin versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention
by Montalescot, Gilles and White, Harvey D and Gallo, Richard and Cohen, Marc and Steg, P. Gabriel and Aylward, Philip E.G and Bode, Christoph and Chiariello, Massimo and King, Spencer B and Harrington, Robert A and Desmet, Walter J and Macaya, Carlos and Steinhubl, Steven R and STEEPLE Investigators
The New England journal of medicine, ISSN 0028-4793, 09/2006, Volume 355, Issue 10, pp. 1006 - 1017
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | General aspects | Medical sciences | Coronary heart disease | Prospective Studies | Anticoagulants - administration & dosage | Hemorrhage - epidemiology | Smoking - blood | Humans | Middle Aged | Anticoagulants - therapeutic use | Heparin - therapeutic use | Male | Anticoagulants - adverse effects | Heparin - adverse effects | Enoxaparin - adverse effects | Incidence | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Angioplasty, Balloon, Coronary - adverse effects | Regression Analysis | Enoxaparin - administration & dosage | Myocardial Ischemia - therapy | Female | Aged | Myocardial Ischemia - mortality | Hemorrhage - chemically induced | Stents | Enoxaparin | Drug therapy | Angioplasty | Health aspects | Cardiac patients | Methods | Anticoagulants | Heart attacks | Acute coronary syndromes | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
by Schwartz, Gregory G and Steg, P. Gabriel and Szarek, Michael and Bhatt, Deepak L and Bittner, Vera A and Diaz, Rafael and Edelberg, Jay M and Goodman, Shaun G and Hanotin, Corinne and Harrington, Robert A and Jukema, J. Wouter and Lecorps, Guillaume and Mahaffey, Kenneth W and Moryusef, Angèle and Pordy, Robert and Quintero, Kirby and Roe, Matthew T and Sasiela, William J and Tamby, Jean-François and Tricoci, Pierluigi and White, Harvey D and Zeiher, Andreas M and ODYSSEY OUTCOMES Comm Inv and ODYSSEY OUTCOMES Committees and Investigators
The New England journal of medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 22, pp. 2097 - 2107
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Cardiovascular Diseases - epidemiology | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - complications | Aged | Acute coronary syndrome | Diagnosis | Myocardial infarction | Fees & charges | Lipoproteins (low density) | Heart attacks | Lipids | Cardiovascular disease | Angina | Apolipoprotein B | Ischemia | Heart diseases | Drug dosages | Statins | Cerebral infarction | Stroke | Subtilisin | Angina pectoris | Patients | Low density lipoprotein | Coronary artery disease | Cholesterol | Kexin | Monoclonal antibodies | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Pharmaceuticals | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of acute coronary syndromes 2016
by Chew, Derek P and Scott, Ian A and Cullen, Louise and French, John K and Briffa, Tom G and Tideman, Philip A and Woodruffe, Stephen and Kerr, Alistair and Branagan, Maree and Aylward, Philip EG
Medical journal of Australia, ISSN 0025-729X, 08/2016, Volume 205, Issue 3, pp. 128 - 133
Cardiovascular diseases | Health services administration | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Emergency Service, Hospital | Humans | Anticoagulants - therapeutic use | Male | Cardiology - standards | Angioplasty, Balloon, Coronary | New Zealand | Acute Coronary Syndrome - rehabilitation | Acute Coronary Syndrome - diagnosis | Acute Coronary Syndrome - therapy | Female | Disease Management | Australia | Platelet Aggregation Inhibitors - therapeutic use | Societies, Medical - standards | Practice Guidelines as Topic | Practice guidelines (Medicine) | Care and treatment | Diagnosis | Acute coronary syndrome | Analysis | Risk factors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization
by Roe, Matthew T and Armstrong, Paul W and Fox, Keith A.A and White, Harvey D and Prabhakaran, Dorairaj and Goodman, Shaun G and Cornel, Jan H and Bhatt, Deepak L and Clemmensen, Peter and Martinez, Felipe and Ardissino, Diego and Nicolau, Jose C and Boden, William E and Gurbel, Paul A and Ruzyllo, Witold and Dalby, Anthony J and McGuire, Darren K and Leiva-Pons, Jose L and Parkhomenko, Alexander and Gottlieb, Shmuel and Topacio, Gracita O and Hamm, Christian and Pavlides, Gregory and Goudev, Assen R and Oto, Ali and Tseng, Chuen-Den and Merkely, Bela and Gasparovic, Vladimir and Corbalan, Ramon and Cinteză, Mircea and McLendon, R. Craig and Winters, Kenneth J and Brown, Eileen B and Lokhnygina, Yuliya and Aylward, Philip E and Huber, Kurt and Hochman, Judith S and Ohman, E. Magnus and TRILOGY ACS Investigators
The New England journal of medicine, ISSN 0028-4793, 10/2012, Volume 367, Issue 14, pp. 1297 - 1309
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | General aspects | Biological and medical sciences | Myocarditis. Cardiomyopathies | Medical sciences | Coronary heart disease | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Myocardial Infarction - epidemiology | Follow-Up Studies | Thiophenes - adverse effects | Ticlopidine - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Angina, Unstable - drug therapy | Ticlopidine - adverse effects | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Kaplan-Meier Estimate | Purinergic P2 Receptor Antagonists - therapeutic use | Piperazines - therapeutic use | Piperazines - adverse effects | Ticlopidine - analogs & derivatives | Purinergic P2 Receptor Antagonists - adverse effects | Acute Coronary Syndrome - drug therapy | Myocardial Infarction - drug therapy | Aged | Myocardial infarction | Cerebral infarction | Aspirin | Heart attacks | Medical imaging | Angina | Angina pectoris | Patients | Bleeding | Ischemia | Patient safety | Clopidogrel | Acute coronary syndromes | Heart diseases | Age | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Impact of a regionalised clinical cardiac support network on mortality among rural patients with myocardial infarction
by Tideman, Philip A and Tirimacco, Rosy and Senior, David P and Setchell, John J and Huynh, Luan T and Tavella, Rosanna and Aylward, Philip E G and Chew, Derek P B
Medical journal of Australia, ISSN 0025-729X, 02/2014, Volume 200, Issue 3, pp. 157 - 160
Cardiovascular diseases | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Length of Stay | Myocardial Infarction - epidemiology | Myocardial Infarction - mortality | Rural Population - statistics & numerical data | Risk Assessment | Comorbidity | Humans | South Australia - epidemiology | Primary Health Care - organization & administration | Hospitals, Rural | Coronary Angiography | Health Services Accessibility | Cardiac Care Facilities - organization & administration | Patient Transfer | Rural Health Services | Diagnosis | Australia | Statistics | Patient outcomes | Mortality | Heart attack | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights